U.S. COMPANY FILING
Medtronic plc — Form 8-K filed 2026-03-24
Filing text preview
Medtronic filed an 8-K on March 24, 2026, disclosing FDA clearance of MiniMed Flex insulin pump earlier than expected. However, a one-time charge of $157 million related to Blackstone payments and IPO dilution will reduce Q4 FY2026 EPS by $0.12, prompting a guidance cut for FY2026 non-GAAP EPS to $5.50-$5.54 from $5.62-$5.66. FY2027 guidance remains unchanged.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record